World's Best Scientists 2026 revealed!
Matteo Bassetti

Matteo Bassetti

Award Badge
Microbiology
Italy
2026

D-Index & Metrics

Microbiology

D-Index
106
Citations
45830
World Ranking
295
National Ranking
3

Medicine

D-Index
108
Citations
47250
World Ranking
5964
National Ranking
187

Research.com Recognitions

  • 2026 - Research.com Microbiology in Italy Leader Award
  • 2025 - Research.com Microbiology in Italy Leader Award

Overview

Matteo Bassetti is affiliated with the University of Genoa in Italy and has contributed extensively to the field of medicine, with a specific emphasis on infectious diseases. Their work spans numerous subfields including infectious diseases, epidemiology, applied microbiology and biotechnology, molecular medicine, and pharmacology.

The scientist's research addresses a broad range of topics related to antimicrobial resistance and infectious disease treatment. Major topics covered in their publications include:

  • Antifungal resistance and susceptibility
  • Antibiotic Use and Resistance
  • Antibiotic Resistance in Bacteria
  • COVID-19 Clinical Research Studies
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • SARS-CoV-2 and COVID-19 Research

Frequent collaborators of Matteo Bassetti include the following researchers:

  • Daniele Roberto Giacobbe
  • Antonio Vena
  • Małgorzata Mikulska
  • Antonio Di Biagio
  • Chiara Dentone

Their research has been published in a variety of specialist journals and outlets, with repeated contributions to several key venues:

  • Infectious Diseases and Therapy
  • Current Opinion in Infectious Diseases
  • Intensive Care Medicine
  • Clinical Microbiology and Infection
  • Open Forum Infectious Diseases

Selected recent papers authored or co-authored by Matteo Bassetti include:

  • "Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial," 2020, The Lancet Infectious Diseases
  • "Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper," 2020, Intensive Care Medicine
  • "Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance," 2020, The Lancet Infectious Diseases
  • "European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)," 2021, Clinical Microbiology and Infection
  • "Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial," 2021, Nature Medicine

Best Publications

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Genetic mechanisms of critical illness in Covid-19.

    E. Pairo-Castineira;E. Pairo-Castineira;S. Clohisey;L. Klaric;A. D. Bretherick

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

    O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino

  • DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

    Jason A. Roberts;Sanjoy K. Paul;Murat Akova;Matteo Bassetti

  • Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy

    Mario Tumbarello;Pierluigi Viale;Claudio Viscoli;Enrico Maria Trecarichi

  • Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper .

    Mohd H. Abdul-Aziz;Jan Willem C. Alffenaar;Jan Willem C. Alffenaar;Matteo Bassetti;Hendrik Bracht

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

    Philipp Koehler;Matteo Bassetti;Arunaloke Chakrabarti;Sharon C.A. Chen;Sharon C.A. Chen

  • Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial

    Patrick N. A. Harris;Patrick N. A. Harris;Patrick N. A. Harris;Paul A. Tambyah;David C. Lye;David C. Lye;David C. Lye;Yin Mo

  • Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

    Stella G Muthuri;Sudhir Venkatesan;Puja R Myles;Jo Leonardi-Bee

  • How to manage Pseudomonas aeruginosa infections.

    Matteo Bassetti;Antonio Vena;Antony Croxatto;Elda Righi

  • Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.

    Matteo Bassetti;Roger Echols;Yuko Matsunaga;Mari Ariyasu

  • Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

    Mario Tumbarello;Enrico Maria Trecarichi;Francesco Giuseppe De Rosa;Maddalena Giannella

  • New antibiotics for bad bugs: where are we?

    Matteo Bassetti;Maria Merelli;Chiara Temperoni;Augusta Astilean

  • Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

    Emanuele Durante-Mangoni;Giuseppe Signoriello;Roberto Andini;Annunziata Mattei

  • Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

    Evdoxia Kyriazopoulou;Garyfallia Poulakou;Haralampos Milionis;Simeon Metallidis

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012:diagnostic procedures

    M. Cuenca-Estrella;P. E Verweij;M. C Arendrup;S. Arikan-Akdagli

  • The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm.

    Matteo Bassetti;Antonio Vena;Daniele Roberto Giacobbe

  • Epidemiological trends in nosocomial candidemia in intensive care.

    Matteo Bassetti;Elda Righi;Alessandro Nanni Costa;Roberta Fasce

  • ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp

    W.W. Hope;E. Castagnola;A.H. Groll;E. Roilides

  • ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

    A.J. Ullmann;M. Akova;R. Herbrecht;C. Viscoli

  • Bloodstream infections in critically ill patients: an expert statement

    Jean François Timsit;Etienne Ruppé;François Barbier;Alexis Tabah

  • Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.

    Paul E. Verweij;Bart J.A. Rijnders;Roger J.M. Brüggemann;Elie Azoulay

Frequent Co-Authors

Elda Righi
Elda Righi University of Verona
Claudio Viscoli
Claudio Viscoli University of Genoa
Mario Tumbarello
Mario Tumbarello Catholic University of the Sacred Heart
Pierluigi Viale
Pierluigi Viale University of Bologna
Federico Pea
Federico Pea University of Udine
Jordi Rello
Jordi Rello Instituto de Salud Carlos III
Jean-François Timsit
Jean-François Timsit Université Paris Cité
Paolo Pelosi
Paolo Pelosi University of Genoa
Jason A. Roberts
Jason A. Roberts University of Queensland
George Dimopoulos
George Dimopoulos National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of healthcare and science-related careers. One interesting pathway is becoming a functional medicine nurse practitioner, a role that combines biology knowledge with patient-centered care to address complex health conditions.

For those interested in the administrative and coding side of healthcare, obtaining a certified professional coder certification can be a valuable credential. This certification enables professionals to accurately translate medical information, including microbiology reports, into standardized codes used for billing and data management.

Another growing field is health information management. Professionals in this area oversee patient data and ensure compliance with healthcare regulations. Understanding the health information management job description and salary can help microbiology graduates evaluate this career path as a stable, well-paying option.

To pursue this, many students explore online health information management degree programs cahiim accredited, which provide flexible learning options with accreditation recognized by employers nationwide. Combining microbiology expertise with health information management skills can significantly boost employability in the healthcare sector.

Best Scientists Citing Matteo Bassetti

Trending Scientists

Recently Published Articles